France and Germany) cross-sectional study that obtained patient consent/approval. Average treatment effects (ATEs) for 1113 patients (156 natalizumab, 711 platform, 246 oral) were estimated and adjusted utilizing a propensity score generated from age, gender, EDSS score at current treatment initiation, line-of-therapy, BMI, duration of current treatment, time since MS diagnosis, and number of comorbid conditions. Physician-reported relapses in the previous 12 months and work productivity were compared across treatments. Results: Relapse and WPAI data were available for 934 (122 natalizumab, 617 platform, 195 oral) and 222 (34 natalizumab, 137 platform, 51 oral) patients, respectively. Natalizumab patients suffered fewer relapses than platform (ATE = − 0.21 vs. 0.48, p = 0.020) and oral therapy patients (ATE = −0.14 vs. 0.45, p = 0.075). Patients receiving natalizumab reported significantly less presenteeism, i.e., attending work while sick) than those receiving platform (ATE = −10.16% vs. 19.26%, p = 0.001) or oral therapies (ATE = −8.28% vs. 22.65%, p = 0.0018). Treatment was not associated with less overall work impairment. Conclusion: Treatment with natalizumab compared to platform or oral therapies was associated with a lower relapse rate and a significant reduction in impairment at work or presenteeism.Sponsored by Biogen.
up program, involving discussions between mentor and group of maximum 10 physicians. Discussion themes were informed by participant survey needs and requests. Results: 135 neurologists and 38 residents attended workshops across 3 host cities. All participants participated in the eMedical program, led by 20 mentors and supported by UCB Medical team. Surveys confirmed medical topics of greatest interest to be covered during the eMedical mentorship: drug interactions, rational polytherapy and cognition in epilepsy. High rate of willingness to continue (N95%) with program was observed. Conclusion: Dandelion touched nearly 30.000 patients lives through the innovative effective educational support of approximately 200 neurologists. There is potential for further expansion of this program in Brazil, and to grow the ''Dandelion Community". UCB-sponsored (1) Accessed on 5 May 2015 at http://apps.who.int/gb/ebwha/ pdf_files/EB136/B136_R8-en.pdf
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.